The Image Gently campaign and the Society of Nuclear Medicine (SNM) have launched the Go With the Guidelines campaign to encourage community hospitals, academic hospitals and clinics to observe new North American Guidelines for Nuclear Medicine Radiopharmaceutical Dose in children.

Surveyed participants in text4baby, a health information text messaging service for pregnant women and mothers of newborn infants, reported high levels of user satisfaction, according to researchers from the University of California San Diego (UCSD) and the National Latino Research Center (NLRC).

An aging global population seeking care for cardiovascular, oncological and neurological disorders will drive the worldwide market for radiopharmaceuticals to more than $6.5 billion by 2017.

Kalamazoo, Mich.-based medical device manufacturer Stryker has announced a plan to cut approximately 5 percent of its workforceamong other restructuring decisionsin an effort to reduce pre-tax operating costs by more than $100 million in 2013.

Philips Speech Processing, a mobile and stationary dictation system manufacturer, has announced the availability of SpeechControl4Mac. The Vienna-based companys software will allow Philips SpeechMike desktop dictation device to operate on Macintosh operating systems.

Dunlee (Booth 4003) is unveiling a new line of tubes for advanced CT applications, as well as an expanded customer application for electronic tutorials on the removal, installation and calibration of CT tubes at the 97th Annual Meeting & Scientific Assembly of the RSNA, Nov. 27 to Dec. 2 in Chicago.

The FDA has given its first green light to a stem-cell transplantation product using umbilical-cord blood. Hemacord, produced by the New York Blood Center, is intended to treat patients with disorders affecting the blood- forming system, such as certain blood cancers and inherited metabolic and immune system disorders.

The large-scale ADAPT-DES registry, which assessed platelet reactivity with a variety of platelet function tests in more than 8,500 patients, reaffirmed that the tests have not found an appropriate place in routine clinical practice. The study was presented Nov. 9 at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) conference.